How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

527 results for

Postpartum Inpatient Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology and The Obesity Society

@aace.com. DOI:10.4158/EP13155.GL To purchase reprints of this article, please visit: www.aace.com/reprints. Copyright © 2013 AACE4 Clinical Practice Guidelines for Healthy Eating, Endocr Pract. 2013;19(Suppl 3) healthy eating and physical activity. Yet, to date there is no evidence-based clinical practice guideline (CPG) to define the standards of care for healthy eating in the management and prevention of metabolic and endocrine disorders. This joint effort of AACE and TOS addresses this deficit (...) reduction, and happiness (Grade A, BEL 1). 3.Q1.2 Healthy Macronutrient Intake • R2. In a healthy eating meal plan, carbohydrates should provide 45 to 65% of ingested energy, with due diligence to limit simple sugars or foods that have a high glycemic index (GI). Regardless of the macronutrient mix, total caloric intake must be appropriate for individual weight manage- ment goals. Patients should consume 6 to 8 serv- ings of carbohydrates (one serving is 15 grams of carbohydrate) per day with at least

2013 American Association of Clinical Endocrinologists

182. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

of the panel was facilitated by faculty of the University of Pittsburgh School of Pharmacy and University of Pittsburgh Medical Center Drug Use and Disease State Management Program who served as contract researchers and writers for the project. Panel members and contractors were required to disclose any possible conflicts of interest before their appointment and throughout the guideline development process. Drafted documents for each surgical procedural section were reviewed by the expert panel and, once

Full Text available with Trip Pro

2013 Infectious Diseases Society of America

183. Ethical Issues With Vaccination for the Obstetrician?Gynecologist

of reproductive age receive in the course of well-woman care. The preconception and postpartum periods are other prime opportunities for vaccination against potentially dangerous or teratogenic infectious agents, such as rubella, that could affect future pregnancies ( ). Vaccinations also play a central role in the prevention and control of acute outbreaks, as in the case of seasonal influenza or pandemics. Recent attention has focused on potentially preventable human papillomavirus (HPV) infections among (...) , although termination of the physician–patient relationship is a possible option, it is often counterproductive and disruptive. Instead, College Fellows have the opportunity to put alternative strategies into place to protect the health of the patient and that of the general community. Such strategies include patient education to monitor and manage symptoms at home and behavioral approaches to reduce risk associated with infection and transmission. Although these strategies help to mitigate harms

2013 American College of Obstetricians and Gynecologists

184. HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV

HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV RECOMMENDATIONS FOR A PUBLIC HEALTH APPROACH AND CONSIDERATIONS FOR POLICY-MAKERS AND MANAGERS HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING WITH HIV United Nations Educational, Scienti?c and Cultural Organization ISBN 978 92 4 150616 8 HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING WITH HIV ? World (...) Health Organization 20, avenue Appia CH–1211 Geneva 27 Switzerland For more information, contact: ? Department of HIV/AIDS E-mail: hiv-aids@who.int http://www.who.int/hiv/en/ ? Department of Maternal, Newborn, Child and Adolescent Health Email: mncah@who.int http://www.who.int/maternal_child_adolescent/en/RECOMMENDATIONS FOR A PUBLIC HEALTH APPROACH AND CONSIDERATIONS FOR POLICY-MAKERS AND MANAGERS HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING

2013 World Health Organisation HIV Guidelines

185. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

Objectives 39 1.4 Target audience 39 1.5 Scope and components 40 1.5.1 Introductory chapters 40 1.5.2 Clinical guidance 40 1.5.3 Operational and service delivery guidance 40 1.5.4 Guidance for programme managers 41 1.5.5 Monitoring and evaluation 41 2. Guiding principles 43 2.1 Contribution to global health goals 44 2.2 Public health approach 44 2.3 Strengthening health systems through innovation and learning 44 2.4 Increasing the effectiveness and efficiency of programmes 45 2.5 Promoting human rights (...) 7.5 What Ar V regimen to switch to (second-line Ar T) 146 7.5.1 Second-line Ar T for adults and adolescents 146 7.5.2 Second-line Ar T for children (including adolescents) 150 7.6 Third-line Ar T 1538 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing hiv infection 8. Clinical guidance across the continuum of care: Managing common coinfections and comorbidities 155 8.1 Prevention, screening and management of common coinfections 156 8.1.1 Co-trimoxazole

2013 World Health Organisation HIV Guidelines

186. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

immediately postpartum ensures reliable contraception for adolescents when they are highly motivated to prevent pregnancy and are already in the health care system, and it is cost effective in decreasing rapid repeat pregnancy ( ). Lack of insurance coverage for inpatient LARC insertion has been an obstacle to immediate postpartum LARC initiation; however, since 2013 increasing numbers of state Medicaid programs have begun covering this service ( ). For additional information, including clinical guidance (...) nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. All ACOG Committee members and authors have submitted a conflict of interest disclosure statement related to this published product. Any potential conflicts have been considered and managed in accordance

2012 American College of Obstetricians and Gynecologists

187. Heart Disease and Stroke Statistics?2012 Update

makers, media professionals, the lay public, and many others who seek the best national data available on disease morbidity and mortality and the risks, quality of care, medical procedures and operations, and costs associated with the management of these diseases in a single document. Indeed, since 1999, the Statistical Update has been cited more than 8700 times in the literature (including citations of all annual versions). In 2010 alone, the various Statistical Updates were cited ≈1600 times (data (...) adherence with guideline recommendations for many, but not all, metrics of quality of care for these hospitalized patients. Data are also reviewed on screening for cardiovascular risk factor levels and control. Cardiovascular Procedure Utilization and Costs Chapter 22 provides data on trends and current usage of cardiovascular surgical and invasive procedures. For example, the total number of inpatient cardiovascular operations and procedures increased 22%, from 6 133 000 in 1999 to 7 453 000 in 2009

Full Text available with Trip Pro

2012 American Heart Association

189. First-trimester abortion in women with medical conditions

renal dysfunction [27]. 3. When is medication abortion preferred over surgical abortion? Patients at risk of surgical and anesthetic complications may benefit from medical management, sometimes in the inpatient setting [15]. Medication abortion may provide a safer alternative for patients with extreme obesity, pelvic tumors that interfere with access to the cervix or a known history of serious reactions to anesthetic agents. Medication abortion, which doesnot require lithotomy positioning, may (...) or postpartum than in the first trimester [44]. Women with a history of asthma without current symptoms mayundergousualcare.Womenwithcurrentwell-controlled asthmashouldbeencouragedtouseusualmedicationsandto bringaninhalerwiththemfortheirabortionvisit.Eveniftheir lungsare clear onauscultation,prophylacticuse ofaninhaler with nebulized albuterol or metaproterenol before the procedure may be prudent. The facility must be equipped to manage the rare acute asthma exacerbations. Concurrent respiratory infection

2012 Society of Family Planning

190. SNMMI Procedure Standard for Therapy of Thyroid Disease with 131I (Sodium Iodide) 3.0

University Medical Center, Nashville, Tennessee; 11 Beth Israel Deaconess Medical Center, Boston, Massachusetts; 12 Mallinckrodt Institute of Radiology, St. Louis, Missouri; 13 Jacobi Medical Center, Bronx, New York; 14 Vanderbilt University, Nashville, Tennessee; and 15 Cedars-Sinai Medical Center, Los Angeles, California INDEX Preamble 1 I. Introduction: patient management, licensure 2 II. Goals 2 III. De?nitions: risk levels 2 IV. Common clinical indications 3 V. Quali?cations and responsibilities (...) disorders of the thyroid since the 1940s. Physicians respon- sible for treating such patients should have an understand- ing of the clinical pathophysiology and natural history of the disease processes, should be familiar with alternative forms of therapy, and should be able to collaborate closely with other physicians involved in the management of the patient’s condition. The treating physician should either see patients inconsultationwiththephysicianassumingoverall management of the patient’s

2012 Society of Nuclear Medicine and Molecular Imaging

191. Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee Arthroplasty

Turkelson Ph.D Director of Research & Scientific Affairs 6300 N River Road Rosemont, IL 60018 Janet L Wies MPH Manager, Clinical Practice Guidelines wies@aaos.org Patrick Sluka MPH Lead Research Analyst Sluka@aaos.org Kristin Hitchcock MIS AAOS Medical Librarian ix Peer Review Organizations Participation in the AAOS peer review process does not constitute an endorsement of this guideline by the participating organization. The following organizations participated in peer review of this clinical practice (...) . In addition to providing practice recommendations, this guideline also highlights gaps in the literature and areas that require future research. This guideline is intended to be used by all appropriately trained surgeons and all qualified physicians managing the prevention of venous thromboembolic (VTE) disease in patients undergoing elective hip and knee arthroplasty. GOALS AND RATIONALE The purpose of this clinical practice guideline is to help improve screening, prevention, and treatment based

2011 American Academy of Orthopaedic Surgeons

192. Adapting WHO normative HIV guidelines for national programmes

and treatment 67 Additional resources 71 Adaptation guides and resources 71 Guidance on programme design and management 71 References 72 iii Annexes 74 Annex 1 Sample declaration of interests form (WHO, 2010) 75 Annex 2 Suggested approach for a situation analysis and feasibility assessment for antiretroviral therapy in adults and adolescents 79 Annex 3 Suggested approach for a situation analysis and feasibility assessment for prevention of mother-to-child transmission programmes 83 Annex 4 Risk–benefit (...) analysis checklist 87 Case studies 88 Case study 1: Implications of early initiation of antiretroviral therapy, Malawi 89 Case study 2: Phasing out the use of stavudine in first-line antiretroviral regimens, Uganda 90 Case study 3: Implementing point of care CD4 testing, Mozambique 91 Case study 4: Costing PMTCT Options A and B, Tanzania 92 Case study 5: Implementing Option B of the WHO 2010 PMTCT guidelines, Thailand 93 Case study 6: Nurse initiation and management of ART, Lesotho 94 Case study 7

2011 World Health Organisation HIV Guidelines

193. Chronic thromboembolic pulmonary hypertension, pregnancy, and a pulmonary endarterectomy: a rare challenge (PubMed)

endarterectomy (PEA) has not been previously reported. We report the case of a 28-year-old woman who received a diagnosis of CTEPH during her pregnancy, was managed as an inpatient by a multidisciplinary team throughout the pregnancy and early postpartum period, and underwent PEA 6 weeks after delivery. While the management of acute pulmonary embolus in pregnancy is well described, this unique case of CTEPH diagnosed during pregnancy illustrates several challenging management issues. (...) Chronic thromboembolic pulmonary hypertension, pregnancy, and a pulmonary endarterectomy: a rare challenge It is well described that patients with group 1 forms of pulmonary arterial hypertension have a high risk of mortality during pregnancy and in the early postpartum period. However, to the authors' knowledge, the diagnosis and management of group 4 pulmonary hypertension due to chronic thromboembolic pulmonary hypertension (CTEPH) during pregnancy with early postpartum pulmonary

Full Text available with Trip Pro

2016 Pulmonary circulation

194. Physical Therapy in Addition to Standard Care Following C-Section

): Jennifer Y Stone, University of Missouri-Columbia Study Details Study Description Go to Brief Summary: The purpose of this study is to determine whether a physical therapy program which includes scar management, core retraining, and lumbar and pelvic joint mobilization will significantly impact the postpartum recovery following Cesarean section during the immediate postpartum period and during the first 1.5 years following childbirth. All patients who enroll in the study will receive standard treatment (...) compared to an unassisted vaginal delivery (estimates range from 2-5 times increase). The purpose of this study is to determine whether a physical therapy program which includes scar management, core retraining, and lumbar and pelvic joint mobilization will significantly impact the postpartum recovery following Cesarean section during the immediate postpartum period and during the first 1.5 years following childbirth. Study Design Go to Layout table for study information Study Type : Interventional

2016 Clinical Trials

195. Evaluation of the Implementation and Effectiveness of IPP-HPV

infection, lower rates of cervical and other HPV associated cancers, and address cancer disparities. Condition or disease Intervention/treatment Phase HPV Vaccination Drug: HPV vaccine Behavioral: Inpatient Postpartum HPV Immunization Quality Improvement Program Not Applicable Detailed Description: Administration of the HPV vaccine during the inpatient postpartum hospital stay has the potential to be an innovative intervention to improve HPV immunization rates. Following onset of pregnancy (...) , the postpartum period becomes the next available opportunity to immunize with the HPV vaccine, which is safe in breastfeeding women. The benefits of such an intervention include a focus on women engaged with the health care system who are often highly motivated to invest in their personal health. Specific Aims Aim 1: To evaluate receptivity and concerns of postpartum women with receiving the HPV vaccine during the inpatient postpartum admission as part of the Inpatient Postpartum HPV Immunization Quality

2016 Clinical Trials

196. Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder

Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Use (...) polytherapy in pregnant women diagnosed with bipolar disorder. To assess the impact of antipsychotics, antidepressants, and antipsychotic-antidepressant polytherapy on the risk of maternal, neonatal, and labour and delivery outcomes in women with bipolar disorder. To assess the impact of antipsychotics, antidepressants, antipsychotic-antidepressant polytherapy on psychiatric readmission rates during the early postpartum period in women with bipolar disorder. Condition or disease Intervention/treatment

2016 Clinical Trials

197. Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

and mitochondrial disorders) Morbid obesity (body mass index ≥ 40 kg/m²) Women who are within 2 weeks postpartum and are not breastfeeding Exclusion Criteria: Patients with severe influenza virus infection requiring inpatient treatment. Patients with known allergy to oseltamivir (Tamiflu®). Patients unable to swallow tablets or capsules. Patients who have previously received Baloxavir Marboxil. Patients weighing ≤ 40 kg. Patients who have been exposed to an investigational drug within 30 days prior (...) Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2016 Clinical Trials

198. Effect of Nutritional Products in Subjects With Type 2 Diabetes

Effect of Nutritional Products in Subjects With Type 2 Diabetes Effect of Nutritional Products in Subjects With Type 2 Diabetes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect of Nutritional Products (...) . To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 70 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Subject has type 2 diabetes Subject is a male or a nonpregnant, nonlactating female, at least 6 weeks postpartum prior to screening visit Subject's BMI

2016 Clinical Trials

199. Outpatient Foley For Starting Induction of Labor at TErm

Outpatient Foley For Starting Induction of Labor at TErm Outpatient Foley For Starting Induction of Labor at TErm - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Outpatient Foley For Starting Induction (...) at Birmingham Information provided by (Responsible Party): Spencer G. Kuper, University of Alabama at Birmingham Study Details Study Description Go to Brief Summary: The investigators are performing a randomized controlled-trial investigating starting cervical ripening in the outpatient setting with a mechanical method, the transcervical Foley catheter. This is a pilot study to establish the efficacy of this method in decreasing time as in inpatient and evaluate patient satisfaction. Condition or disease

2016 Clinical Trials

200. Maternal and neonatal outcomes of pregnancies in women with Addison's disease: a population-based cohort study on 7.7 million births. (PubMed)

Maternal and neonatal outcomes of pregnancies in women with Addison's disease: a population-based cohort study on 7.7 million births. To assess if pregnancies among women with Addison's disease (AD) are at higher risk of adverse maternal and neonatal outcomes.Population-based retrospective cohort study.All births in the United States' Healthcare Cost and Utilization Project-Nationwide Inpatient Sample from 2003 to 2011.Baseline characteristics were compared between women with AD and those (...) by caesarean section (OR 1.32, 95% CI 1.08-1.61), have impaired wound healing (OR 4.28, 95% CI 2.55-7.18), develop infections (OR 2.44, 95% CI 1.66-3.58) and develop thromboembolism (OR 5.21, 95% CI 2.15-12.63), require transfusions (OR 6.69, 95% CI 4.69-9.54), and have prolonged postpartum hospital admissions (OR 5.71, 95% CI 4.37-7.47). Maternal mortality was significantly higher than in the comparison group (OR 22.30, 95% CI 6.82-72.96). Congenital anomalies (OR 3.62, 95% CI 2.05-6.39) and small

Full Text available with Trip Pro

2016 BJOG

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>